| Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: in vitro and in vivo evaluation S Inugala, BB Eedara, S Sunkavalli, R Dhurke, P Kandadi, R Jukanti, ... European Journal of Pharmaceutical Sciences 74, 1-10, 2015 | 163 | 2015 |
| Inhalation delivery for the treatment and prevention of COVID-19 infection BB Eedara, W Alabsi, D Encinas-Basurto, R Polt, JG Ledford, ... Pharmaceutics 13 (7), 1077, 2021 | 59 | 2021 |
| The influence of surface active l-leucine and 1, 2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) in the improvement of aerosolization of pyrazinamide and moxifloxacin co … BB Eedara, B Rangnekar, C Doyle, A Cavallaro, SC Das International journal of pharmaceutics 542 (1-2), 72-81, 2018 | 57 | 2018 |
| Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis BB Eedara, IG Tucker, SC Das International journal of pharmaceutics 506 (1-2), 174-183, 2016 | 57 | 2016 |
| A Gelucire 44/14 and labrasol based solid self emulsifying drug delivery system: formulation and evaluation VR Kallakunta, BB Eedara, R Jukanti, RK Ajmeera, S Bandari Journal of Pharmaceutical Investigation 43, 185-196, 2013 | 51 | 2013 |
| Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies BB Eedara, PR Veerareddy, R Jukanti, S Bandari Drug Development and Industrial Pharmacy 40 (8), 1030-1043, 2014 | 46 | 2014 |
| Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: in vitro and in vivo evaluation B Ramasahayam, BB Eedara, P Kandadi, R Jukanti, S Bandari Drug development and industrial pharmacy 41 (5), 753-763, 2015 | 42 | 2015 |
| Spray-dried inhalable powder formulations of therapeutic proteins and peptides BB Eedara, W Alabsi, D Encinas-Basurto, R Polt, HM Mansour AAPS PharmSciTech 22 (5), 185, 2021 | 39 | 2021 |
| Development and preliminary characterization of levofloxacin pharmaceutical cocrystals for dissolution rate enhancement S Bandari, VR Dronam, BB Eedara Journal of Pharmaceutical Investigation 47, 583-591, 2017 | 37 | 2017 |
| Development and characterization of high payload combination dry powders of anti-tubercular drugs for treating pulmonary tuberculosis BB Eedara, B Rangnekar, S Sinha, C Doyle, A Cavallaro, SC Das European Journal of Pharmaceutical Sciences 118, 216-226, 2018 | 35 | 2018 |
| Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis B Rangnekar, MAM Momin, BB Eedara, S Sinha, SC Das International journal of pharmaceutics 570, 118689, 2019 | 32 | 2019 |
| In vitro dissolution testing of respirable size anti-tubercular drug particles using a small volume dissolution apparatus BB Eedara, IG Tucker, SC Das International journal of pharmaceutics 559, 235-244, 2019 | 30 | 2019 |
| Improved dissolution rate and intestinal absorption of fexofenadine hydrochloride by the preparation of solid dispersions: In vitro and in situ evaluation BB Eedara, D Nyavanandi, S Narala, PR Veerareddy, S Bandari Pharmaceutics 13 (3), 310, 2021 | 28 | 2021 |
| Nose-to-brain delivery of therapeutic peptides as nasal aerosols W Alabsi, BB Eedara, D Encinas-Basurto, R Polt, HM Mansour Pharmaceutics 14 (9), 1870, 2022 | 27 | 2022 |
| Crystalline adduct of moxifloxacin with trans-cinnamic acid to reduce the aqueous solubility and dissolution rate for improved residence time in the lungs BB Eedara, IG Tucker, ZD Zujovic, T Rades, JR Price, SC Das European Journal of Pharmaceutical Sciences 136, 104961, 2019 | 27 | 2019 |
| Development of ketoprofen loaded proliposomal powders for improved gastric absorption and gastric tolerance: in vitro and in situ evaluation H Gangishetty, BB Eedara, S Bandari Pharmaceutical development and technology 20 (6), 641-651, 2015 | 23 | 2015 |
| Formulation and evaluation of domperidone oral proliposomal powders P Nalla, S Bagam, BB Eedara, R Dhurke Int. J. Pharm. Technol. Res 7, 108-118, 2015 | 20 | 2015 |
| Enhancement of solubility and dissolution rate of Loratadine with Gelucire 50/13 S Bandari, S Jadav, BB Eedara, R Dhurke, R Jukanti Journal of Pharmaceutical Innovation 9, 141-149, 2014 | 20 | 2014 |
| Enhanced solubility and permeability of exemestane solid dispersion powders for improved oral delivery BB Eedara, M Kankane, R Jukanti, VK Nagabandi, S Bandari Journal of Pharmaceutical Investigation 43, 229-242, 2013 | 19 | 2013 |
| A STELLA simulation model for in vitro dissolution testing of respirable size particles BB Eedara, IG Tucker, SC Das Scientific reports 9 (1), 18522, 2019 | 16 | 2019 |
